EFPIA underlines its role in disclosure of pharma payments

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has pointed to the role that it has played over more than a decade in increasing transparency in pharma’s payments to healthcare professionals (HCPs), healthcare organizations (HCOs) and patient organisations (POs).

In 2013, the EFPIA took the proactive step of adding requirements to disclose payments made to HCPs and HCOs in the EFPIA Code of Practice. 

Provisions for the disclosure of payments to patient organizations (POs) were already featured since 2011. The initiative aimed to enhance transparency around transfers of value – financial or in-kind support – between the pharmaceutical industry and HCPs, HCOs and POs.